May 29 |
ProKidney to Participate in the Jefferies Global Healthcare Conference
|
May 23 |
ProKidney: Date Due In Several Days May Enhance Bull Thesis, But I'm Skeptical
|
May 21 |
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
|
May 11 |
We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely
|
May 10 |
ProKidney Corp Reports First Quarter 2024 Financial Results
|
May 10 |
ProKidney reports Q1 results
|
May 10 |
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
|
Mar 25 |
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
|
Mar 22 |
ProKidney GAAP EPS of -$0.57 beats by $0.08
|
Mar 21 |
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
|